AHMED NIZAR: Open Payments
NPI 1063590115 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117,620 in 223 payments from 10 companies in 2025. Trend: 2023 $112,549 · 2024 $116,444 · 2025 $117,620
Speaker / faculty: $95,721Travel & lodging: $14,866Food & beverage: $3,697Consulting: $3,220Education: $117
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 106 | $60,125 |
| Janssen Pharmaceuticals, Inc | 68 | $37,800 |
| Teva Pharmaceuticals USA, Inc. | 13 | $9,882 |
| E.R. Squibb & Sons, L.L.C. | 28 | $9,611 |
| Alkermes, Inc. | 1 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| ABBVIE INC. | 2 | $39 |
| Lundbeck LLC | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: ABILIFY MAINTENA, INVEGA SUSTENNA, REXULTI, UZEDY, COBENFY, ARISTADA, CAPLYTA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
